|

RGL-270 in Combination with PD-1/PD-L1 Inhibitors Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Guangdong Association of Clinical Trials1

Indications

Other1 trial

RGL-270 + ICI in Advanced NSCLC
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.